1. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation
   Jia-Ying Wen et al, 2022, Disease Markers CrossRef
2. Research Progress of Traditional Drug Therapies for Nasopharyngeal Carcinoma by the PI3K/Akt Signaling Pathway
   Qiong Fang et al, 2024, Pharmacognosy Magazine CrossRef